• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Concord Biotech: Stock Market’s New Biotech entrant ready with IPO
  • National Research Foundation (NRF): facing support and resistance from scientific communities! Why?
  • Biodiversity- preserve or perish
  • Dr Rajesh Gokhale assumes charge as Secretary of Department of Science and Technology
  • Advancing allergy detection and management in India: A pathway to improved health
  • Gujarat govt signs MOUs with 15 companies for ₹2000 cr in a single day
  • Pune biotech firm announces cheaper drug for colorectal cancer
  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Processors
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    May 22, 2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Obituary – Hyderabad-based biotechnologist Dr B S Bajaj passes away at 93

Obituary – Hyderabad-based biotechnologist Dr B S Bajaj passes away at 93

0
By Biotech Express on August 16, 2020 Articles

Dr. B.S. Bajaj (DoB: 19/9/1927), founder of Federation of Asian Biotech Associations (FABA), which organizes BioAsia, a  prestigious global Bio Business Forum held every year in Hyderabad in association with the Government of Telangana, passed away on 28th July, 2020.

Dr. B. S. Bajaj, MSc; PhD; FPSI was the Founder and Chairman – All India Biotech Association-Southern Chapter (AIBA-SC), Founder and Secretary General – Federation of Asian Biotech Associations (FABA), and former member, AP Govt. Biotech Advisory Council, former member of Board of Directors of NATCO Pharma Ltd, Pacific Hospital (Pvt) Ltd, Otira Pharmaceuticals Private Ltd., and Transcell Biologics (Pvt) Ltd, Confederation of Indian Industry (CII) and National Committee on Biotechnology.

Dr. B.S. Bajaj had served as General Manager, IDPL, Rishikesh (1981-1985), Executive Director, Torrent Gujarat Biotech Ltd, Vadodara(1991-1998), Director, NATCO Pharma, Hyderabad (2002-2008). He was a member of SBTIC incubation center set up by the Department of Biotechnology, Government of India in Genome valley and also served as a member of Scientific Advisory Committees of CSIR Laboratories. He was the Vice-Chairman of Export Promotion Forum in Biotechnology, Govt. of India. He had over 50 years of experience in R&D in the areas of pharmaceuticals and antibiotics in India.

Dr. Bajaj has made immense contribution in the growth of Pharma and Biotechnology industries in India. In 1980’s while working in Indian Drugs and Pharmaceutical Limited (IDPL) Rishikesh, Vidharbhaa, he played a key role in getting technology transfer for antibiotic research and manufacturing from different countries to Indian Pharma companies. With this technology transfer agreement, Indian Pharma companies could manufacture drugs at a much cheaper cost.

He was instrumental in expansion and modernization of IDPL, Rishikesh plant and setting up of grass-root highly automatic Penicillin G fermentation plant at Baroda, from design to commissioning and stabilization. He thus made significant contribution to make the Country self-sufficient from 80% import of domestic requirements to surplus availability from indigenous sources, together with some other Units. In the academic front, he had a strong R&D experience, had published more than 75 scientific publications and guided several students for post-graduate and PhD Degrees.

He had spent more than a decade in creating global bio-business and Pharma platforms and forums to drive investments into these sectors in India. Under the fold of FABA and BioAsia Dr. Bajaj boosted bio-economy in India, particularly to the state of erstwhile Andhra Pradesh and the present Telangana.

Through his superior leadership and exceptional professionalism, he had been able to efficiently conduct several bio-partnering meetings involving prestigious multinational companies (MNCs) leading to millions of dollars of investments in India. He played a key role in bringing biotech policy for the state of earlier Andhra Pradesh and recommended the same to Government of India.

Several memoranda of understanding (MOUs) had been signed with the international organizations like BioCat of Spain, Catalonia Government, European Federation of Biotechnology, Russian Biotechnology Society, Association of German Biotech Companies (VBU), Bio-industry Park Canavese, Italy to bring together industry in all these countries with India. His most distinguished achievement has been bringing 20 Asian countries under the fold of Federation of Asian Biotech Associations and help in bilateral agreements for export of medicines.

Dr.Bajaj had worked with the local Government in bringing biotech cluster under one roof called “Genome Valley”. Today Genome Valley is the most successful bio-cluster in the country with 300+ Pharma and Biotech companies- major, small and medium range including start-up companies. The Genome Valley has prestigious companies like Bharath Biotech and Biological E- Limited producing vaccines; Novartis, Vimta Lab and others. I consider this was the most notable achievement of Dr. Bajaj.

Dr. Bajaj ensured industry-academia interface and helped formulate the first biotech policy of Telangana that paved the way for the growth of Genome Valley and BioAsia as an annual event to showcase it. He has spent more than a decade in creating global bio-business and Pharma platforms and form to drive investments into these sectors in India. Through superior leadership and exceptional commitment and professionalism, he had been able to efficiently conduct several bio-partnering meetings involving prestigious MNCs leading to millions of dollars of investments into India. Dr. Bajaj has given to India and the world, BioAsia, to boost bio-economy globally.

BioAsia also provided the platform to recognise the services rendered by distinguished scientists to the field of Biotechnology through “Genome Valley Excellence Awards”, and FABA Special Award”, for young scientists in the form of “BioAsia Innovation Awards” and students with “Young Minds Awards”. Some of these awardees include Nobel Laureates and other distinguished scientists around the world. Some of these include Dr. MK Bhan, Prof. E. Premkumar Reddy, Prof. G. Padmanabhan, Prof. Guntaka V Rama Reddy etc.

Dr. Bajaj had bestowed with several awards which include, BioAsia 2008 Award, Maryland India Business Roundtable (MIBRT), Inc., U.S.A bestowed him with an award for “Global leadership, commitment, vision and efforts to promote Biotechnology and Life Sciences for the last 50 years and for organizing BioAsia conferences” and Government of Catalonia (Spain) felicitation for fostering partnership between Andhra Pradesh and Catalonia, State of Spain, in Biotechnology on February 3, 2010, during BioAsia by presenting a Gold Plate with citation and a letter of appreciation from the Vice President of Catalonia Government. During BioAsia 2019, the Global Bio Business Forum, Dr. Bajaj was awarded with the FABA Lifetime Achievement Award for his significant contribution in the growth of biotechnology in India.

Another dream project of Dr. Bajaj was FABA Academy, which he witnessed its launching on 19th Feb, 2020 during BioAsia 2020. FABA Academy forms a bridge between the Academy and Industry in human resources development. The focus is on skill development among the science graduates and post graduates so as to make them industry-ready. The EC members of FABA and the Advisory committee of FABA Academy are highly indebted to Dr. Bajaj for conceptualizing a forum that enables the academy and industry together and for providing a global platform to promote Parma and Biotech industry in the form of BioAsia.

Prof. P Reddanna
Executive President,
Federation of Asian Biotech Association (FABA)
FABA website: http://biofaba.org/

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

National Research Foundation (NRF): facing support and resistance from scientific communities! Why?

Biodiversity- preserve or perish

Advancing allergy detection and management in India: A pathway to improved health

Leave A Reply Cancel Reply

Current Issue – July 2023
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Concord Biotech: Stock Market’s New Biotech entrant ready with IPO July 31, 2023
  • National Research Foundation (NRF): facing support and resistance from scientific communities! Why? July 25, 2023
  • Biodiversity- preserve or perish July 24, 2023
  • Dr Rajesh Gokhale assumes charge as Secretary of Department of Science and Technology July 23, 2023
  • Advancing allergy detection and management in India: A pathway to improved health July 23, 2023
  • Gujarat govt signs MOUs with 15 companies for ₹2000 cr in a single day July 22, 2023
  • Pune biotech firm announces cheaper drug for colorectal cancer July 21, 2023
  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Processors July 20, 2023
  • BMJ Open retracted a diabetes paper because it was funded by tobacco company July 19, 2023
  • Indian scientist made First Marwari horse foal through Embryo transfer technology July 12, 2023
  • Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society May 22, 2023
  • FABA holds Conference on Antimicrobial Resistance Stewardship Series May 22, 2023
  • COVID no longer a global health emergency, WHO says May 18, 2023
  • Chemist in India loses seven papers of biology, blames outsourcing of images May 17, 2023
  • Indian Research scholars express frustration over DST’s tweet, plan stir May 16, 2023
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.